Literature DB >> 29761148

Mortality Associated with Hepatobiliary Disease in Portugal between 2006 and 2012.

Manuel Coelho da Rocha1, Rui T Marinho1, Teresa Rodrigues1.   

Abstract

INTRODUCTION: Hepatobiliary disease is becoming a major public health problem, and recent data suggest that the burden of liver disease is higher than previously thought. Our aim was to quantify the mortality from hepatobiliary disease in Portugal and to compare this with the mortality related o other causes over a 7-year period (2006-2012).
MATERIALS AND METHODS: A statistical analysis of mortality data according to cause, sex, age, and region from the National Statistics Institute in Portugal was carried out. The data related to 14 causes of death, the most frequent of which were alcoholic liver disease (ALD) (International Classification of Diseases code K70), unspecified cirrhosis of liver (UCL) (K74.6), hepatocellular carcinoma (HCC) (C22.0), unspecified malignant neoplasm of liver (C22.9), and cholangiocarcinoma (C22.1).
RESULTS: Between 2006 and 2012, 18,279 deaths (24.5/100,000) from hepatobiliary disease were registered in Portugal, constituting the 8th leading cause of death. The main causes of death from hepatobiliary disease were ALD (7.1/100,000), UCL (5.5/100,000), and HCC (4.3/100,000), with a male predominance (72%). ALD was the main aetiology in younger age groups (40-65 years), while primary neoplasms of the liver and the intrahepatic bile ducts were predominant in the elderly (>80 years). The mortality related to HCC increased by 66% between 2006 and 2012.
CONCLUSION: These data outline the burden of hepatobiliary disease in Portugal (8th cause of death) and highlight a potential impact on economic productivity.

Entities:  

Keywords:  Alcoholic liver disease; Hepatobiliary disease; Hepatocellular carcinoma; Mortality

Year:  2017        PMID: 29761148      PMCID: PMC5939859          DOI: 10.1159/000484868

Source DB:  PubMed          Journal:  GE Port J Gastroenterol        ISSN: 2387-1954


  28 in total

1.  Epidemiological aspects of hepatitis C in Portugal.

Authors:  R T Marinho; M C Moura; J A Giria; P Ferrinho
Journal:  J Gastroenterol Hepatol       Date:  2001-09       Impact factor: 4.029

Review 2.  Global epidemiology and burden of HCV infection and HCV-related disease.

Authors:  Aaron P Thrift; Hashem B El-Serag; Fasiha Kanwal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 46.802

3.  Burden of digestive diseases in Portugal: trends in hospitalizations between 2000 and 2010.

Authors:  Inês Pinho; João Vasco Santos; Mário Dinis-Ribeiro; Alberto Freitas
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-03       Impact factor: 2.566

4.  Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.

Authors:  Rainer Weber; Caroline A Sabin; Nina Friis-Møller; Peter Reiss; Wafaa M El-Sadr; Ole Kirk; Francois Dabis; Matthew G Law; Christian Pradier; Stephane De Wit; Börje Akerlund; Gonzalo Calvo; Antonella d'Arminio Monforte; Martin Rickenbach; Bruno Ledergerber; Andrew N Phillips; Jens D Lundgren
Journal:  Arch Intern Med       Date:  2006 Aug 14-28

Review 5.  Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection.

Authors:  Shu-Chun Chuang; Carlo La Vecchia; Paolo Boffetta
Journal:  Cancer Lett       Date:  2008-12-16       Impact factor: 8.679

6.  Overweight and obesity in Portugal: national prevalence in 2003-2005.

Authors:  I do Carmo; O Dos Santos; J Camolas; J Vieira; M Carreira; L Medina; L Reis; J Myatt; A Galvão-Teles
Journal:  Obes Rev       Date:  2007-11-23       Impact factor: 9.213

7.  Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3beta kinase pathways.

Authors:  Wan-Jen Yang; Ching-Ju Chang; Shiou-Hwei Yeh; Wei-Hsiang Lin; Sheng-Han Wang; Ting-Fen Tsai; Ding-Shinn Chen; Pei-Jer Chen
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

8.  MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.

Authors:  Wan-Hsin Liu; Shiou-Hwei Yeh; Cho-Chun Lu; Sung-Liang Yu; Hsuan-Yu Chen; Chien-Yu Lin; Ding-Shinn Chen; Pei-Jer Chen
Journal:  Gastroenterology       Date:  2008-11-01       Impact factor: 22.682

9.  1 and 5 year survival estimates for people with cirrhosis of the liver in England, 1998-2009: a large population study.

Authors:  Sonia Ratib; Kate M Fleming; Colin J Crooks; Guruprasad P Aithal; Joe West
Journal:  J Hepatol       Date:  2013-10-12       Impact factor: 25.083

10.  An observational study of the direct costs related to hospital admissions, mortality and premature death associated with liver disease in Portugal.

Authors:  Sofia Vitor; Rui Tato Marinho; José Gíria; José Velosa
Journal:  BMC Res Notes       Date:  2016-02-03
View more
  1 in total

1.  Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis.

Authors:  Jen-Kuei Peng; Nilay Hepgul; Irene J Higginson; Wei Gao
Journal:  Palliat Med       Date:  2018-10-22       Impact factor: 4.762

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.